Know Cancer

or
forgot password

A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation


N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation


Inclusion Criteria:



- woman treated with anastrozole as adjuvant therapy for hormone-dependant breast
cancer in post-menopausal women with positive hormone-receptors

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

AstraZeneca France Medical Director

Investigator Role:

Study Director

Investigator Affiliation:

AstraZeneca

Authority:

France: Conseil National de l'Ordre des M├ędecins

Study ID:

NIS-OFR-ARI-2005/1

NCT ID:

NCT00542594

Start Date:

November 2005

Completion Date:

June 2011

Related Keywords:

  • Breast Cancer
  • breast cancer
  • anastrozole
  • Breast Neoplasms

Name

Location